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Abstract Both, DNA and RNA nucleoside modifications
contribute to the complex multi-level regulation of gene
expression. Modified bases in tRNAs modulate protein
translation rates in a highly dynamic manner. Synonymous
codons, which differ by the third nucleoside in the triplet
but code for the same amino acid, may be utilized at dif-
ferent rates according to codon–anticodon affinity.
Nucleoside modifications in the tRNA anticodon loop can
favor the interaction with selected codons by stabilizing
specific base pairs. Similarly, weakening of base pairing
can discriminate against binding to near-cognate codons.
mRNAs enriched in favored codons are translated in higher
rates constituting a fine-tuning mechanism for protein
synthesis. This so-called codon bias establishes a basic
protein level, but sometimes it is necessary to further adjust
the production rate of a particular protein to actual
requirements, brought by, e.g., stages in circadian rhythms,
cell cycle progression or exposure to stress. Such an
adjustment is realized by the dynamic change of tRNA
modifications resulting in the preferential translation of
mRNAs coding for example for stress proteins to facilitate
cell survival. Furthermore, tRNAs contribute in an entirely
different way to another, less specific stress response
consisting in modification-dependent tRNA cleavage that
contributes to the general down-regulation of protein syn-
thesis. In this review, we summarize control functions of
nucleoside modifications in gene regulation with a focus on
recent findings on protein synthesis control by tRNA base
modifications.
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Introduction
Eukaryotic gene expression is controlled at many levels
and modified nucleosides participate at several stages.
DNA cytosine methylation regulates transcription rate
through promoter CpG island methylation. Promoter
methylation is lower in transcriptionally active genes. In
addition, DNA cytosine methylation cooperates with his-
tone modifications which determine the degree of DNA
packaging into strings of nucleosomes and thus the general
accessibility of the DNA for transcription [1]. The post-
transcriptional regulation of gene expression affects the
maturation, nuclear export and stability of messenger
RNAs (mRNAs), and the control of protein translation
initiation. mRNAs are synthesized as precursors (pre-
mRNAs) which are the substrates for mRNA processing [2]
including splicing [3], 50-end capping, and 30-end poly-
adenylation. A methylated guanine nucleoside (m7G)
linked to the mRNA through a 50-50 triphosphate linkage
builds the 50-cap which is required for the nuclear export.
In the cytoplasm, the stability of mRNAs is regulated by
the length of the polyA tail and by RNA interference
(RNAi) mechanisms [4]. Furthermore, RNA base modifi-
cations such as N(6)-methyladenosine (m6A) influence the
decoding process, as well as the stability and function of
mRNAs through interaction with specific RNA binding
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proteins [5, 6]. The translation initiation is considered to be
the rate-limiting step of peptide synthesis and is regulated
by the availability of translation initiation factors and
specific sequence elements within the 50- and 30-UTRs of
the mRNAs [7]. tRNAs play a central role in the control of
protein translation rates due to their function at the inter-
face between mRNA and protein sequence, and tRNA
nucleoside modifications contribute as important regulatory
elements [8, 9]. In this review, we provide a short summary
and an update about the influence of dynamic base modi-
fications in various RNA species on protein translation with
a focus on tRNA.
The functional diversity of tRNAs
Classically, tRNAs link mRNA and protein sequence
information carrying amino acids to the ribosomes
according to codon recognition. Research of the last years
greatly increased the palette of tRNA functions (Fig. 1).
For instance, tRNAs are used for adding amino acids to
other substrates than the growing peptide chain, such as
membrane lipids, proteins or antimicrobial agents [10].
Under stress some tRNAs are cleaved into halves creating
molecules with signaling function [11], while shorter tRNA
derived fragments can function as miRNAs [12–16].
Double stranded RNA fragments cleaved from the mature
tRNAs repressed the translation of specific target mRNAs
in mature human B cells [14], suppressed the expression of
endogenous viruses [15, 16] or were required for prolifer-
ation of a colorectal carcinoma cell line [12].
The tRNA molecules carry a majority of post-tran-
scriptionally modified nucleosides, as they contain almost
90 out of total ca. 150 found in DNA and various classes of
RNA (http://modomics.genesilico.pl; http://mods.rna.
albany.edu) [17, 18]. Some tRNA base modifications are
required to stabilize their tertiary structure. Consequently,
they also influence aminoacylation rate and accuracy [19].
Other base modifications participate in the regulatory
functions of tRNAs (Fig. 2). tRNA modifications were
demonstrated to control tRNA cleavage [20–23]. Modifi-
cations influence the tRNA-mRNA interaction to either
stabilize cognate Watson–Crick base pairing or to facilitate
wobble base pairing to increase the coding capacity [24].
Base modification-mediated strengthening of codon–anti-
codon binding also prevents frame-shift errors [25].
Importantly, some base modifications show dynamic
changes triggered by, e.g., stages in circadian rhythms, in
cell cycle progression, or by environmental factors such as
nutrition or stress [26].
Various functions of tRNA derived fragments
in stress responses
Stressed eukaryotic cells rapidly shut down the overall
translation rate [27]. It was found that in certain stress con-
ditions, tRNA halves are generated by cleavage of tRNA
molecules in the anticodon loop [28]. In mammalian cells,
the cleavage reaction is carried out by angiogenin, a secreted
ribonuclease with angiogenic function (induction of blood
vessel growth). In normal conditions, angiogenin is spatially
segregated from cytoplasmic tRNAs and bound to its specific
inhibitor, RNH1, which controls localization and activity of
the enzyme [29]. Under oxidative stress, angiogenin is
released into the cytoplasm. After activation, angiogenin first
cleaves the 30-CCA termini of tRNAs which prohibits the
usage of tRNAs in translation [30]. This cleavage is rever-
sible and becomes quickly repaired. Cleavage in the
anticodon loop, however, creates tRNA halves and induces
stress granule formation where those mRNAs not needed for
Fig. 1 Functional diversity of
tRNA (the tRNA structure was
taken from RCSB protein data
bank (PDB), file 3IOu)
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the stress response are captured into an inactive state [31].
Also angiogenin becomes concentrated in stress granules
[32]. Stress granule formation depends on the presence of 50-
tRNA halves, the 30-halves being inactive in this regard.
Stress granule formation can be connected to autophagy as
has been clarified recently in yeast. In a process named
granulophagy, stress granules are cleared in lysosomes [33].
In bacteria and yeast strains, the cleavage of the anti-
codon loop has a different function, it is used as defense
mechanism to inhibit competing species. It is exerted by
tRNA specific nucleases, including the bacterial toxins
Colicin E5, Colicin D, and PrrC, as well as Zymocin and
PaT from yeast [34–37]. The fungal anticodon nuclease
PaOrf2 cuts the anticodon loop twice to prevent tRNA repair
which is not possible after two sequential incisions [38].
Importantly, the presence or absence of tRNA modifica-
tions controls tRNA cleavage. In yeast cells for instance, the
final methylation forming the 5-methylcarboxymethyl
(mcm5) modification of uridine in a subset of tRNAs added
by the tRNA-methyltransferase Trm9 transfers resistance to
cleavage by PaT [20]. In the absence of cytosine-5 methy-
lases, tRNAGly and tRNAAsp derived 50-halves cleaved from
non-methylated tRNAs were selectively enriched in mouse
and human [39]. In mammalian cells, lack of methylation
caused by UV light exposure resulted in accumulation of
tRNA halves processed by angiogenin and the cleavage
could be inhibited by the cytosine-5 tRNA methyltransferase
NSun2 [23]. tRNA cleavage by angiogenin could also be
prohibited by cytosine-5 methylation exerted by DNA
methyltransferase 2 (DNMT2) [21, 22]. The tRNA cleavage
in response to oxidative stress was preceded by a confor-
mation change which was demonstrated using an
1-methyladenosine (m1A) antibody specific for unfolded
tRNA [40]. Tissue damage after ischemic reperfusion, toxic
injury, and irradiation increased the concentration of tRNA
halves in the human circulation. The tRNA fragmentation
could be detected before DNA damage providing a diag-
nostically useful early indicator for organ damage [40].
The cleavage of tRNAs in stress conditions does not
significantly reduce the levels of full-length tRNAs, only a
small portion of tRNAs is split. Thus, rather than dimin-
ishing the availability of tRNAs for translation, tRNA
halves exert signaling functions or inhibitory interactions
with the translation machinery. Some tRNA fragments
created by anticodon loop cleavage can bind to and inhibit
proteins required for translation to decrease the global
protein synthesis rate. An example are the fragments
derived from two tRNAGly isoacceptors after cleavage by
angiogenin. These 50-tRNA halves contain a tract of at least
four G-residues at the 50-end and bind eIF4G, a component
Fig. 2 Functions of tRNA modifications
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of the cap-binding eIF4F complex [41]. The importance of
accurate tRNA cleavage control is further underlined by
the fact that accumulation of 50-tRNA halves is associated
with neurological abnormalities in mice and humans as a
consequence of neuronal loss [23].
The 50-tRNA halves derived mainly from tRNAGly and
tRNAVal were found in the circulation of mice also in
unstressed conditions [42]. Interestingly, their concentration
was higher than that of serum miRNAs and changed with
age suggesting a physiological role in the organism. This
hypothesis gains further support by the fact that the corre-
sponding 30 halves were found only in trace quantities [43].
The predominance of 50-tRNA halves over the 30-halves was
impressively confirmed in a study characterizing small RNA
species in the circulation of cattle. Of more than 3 million
tRNA-matched sequence reads, 72.8 % represented 50-
tRNA halves while the proportion of 30-tRNA halves was
less than 0.02 % [44]. Recently it was shown that the length
and relative abundance of tRNA fragments in the human
circulation is heterogeneous and depends on gender and race
[45]. A direct influence of tRNA fragments on the mRNA
stability of specific transcripts was demonstrated lately.
Anticodon loop containing fragments derived from
tRNAGlu, tRNAAsp, tRNAGly, and tRNATyr displaced the
RNA-binding protein YBX1 from the 30-UTR of several
mRNAs resulting in their destabilization and abrogation of
their function in breast cancer progression [43].
Besides the down-regulation of global protein synthesis,
other fascinating functions of tRNAs and tRNA halves were
described. Mitochondrial and cytoplasmatic tRNAs and tRNA
halves were able to inhibit apoptosis through binding to cyto-
chrome C inhibiting its pro-apoptotic signaling function [46,
47]. Furthermore, tRNAVal- and tRNAGly-derived fragments
were increased in ischemic rat brains and negatively regulated
angiogenesis [48]. In breast and prostate cancer cells, sex hor-
mone signaling enhanced tRNA cleavage by angiogenin and
the produced fragments augmented proliferation [49].
There is a very interesting possible interconnection
between the tRNA halves derived from slicing mature
tRNA molecules and the evolution of tRNA which left its
traces in the genomic organization of the tRNA genes:
some tRNAs are encoded by split genes, many others
contain an intron in the anticodon loop sequence so that the
genes encoding the mature tRNAs are presented like
divided into halves [50, 51].
tRNA modifications in protein translation control
Biased codon usage for translation fine-tuning
In general, the availability of tRNAs constitutes a primary
control mechanism for the speed of protein synthesis.
Furthermore, the codon–anticodon binding affinity, which
can be modulated by tRNA base modifications, regulates
the speed and fidelity of translation (Fig. 2) [24, 25].
Certainly, modifications in or around the anticodon loop of
the tRNA molecule exert the strongest influence on trans-
lations rate and accuracy. The tRNA position 34, the
wobble base complement, as well as position 37 adjacent to
the anticodon triplet are very frequently modified to sta-
bilize specific codon—anticodon interactions during the
decoding process. Loss of this stabilizing effect due to
deficiencies in base modifications can be pathologic and
result in severe diseases such as nonsyndromic X-linked
intellectual disability and familial dysautonomia [52–55].
Deregulation of RNA modification pathways has further
been linked to type II diabetes and mitochondria-based
pathologies (Fig. 2) [56].
tRNA nucleoside modifications in and around the anti-
codon loop are employed by the cell to selectively alter the
spectrum of proteins which are preferentially synthesized.
How does this work? The redundancy of the genetic code
allows to choose from alternative codons for the same
amino acid. Different mRNAs vary in the composition of
their synonymous codons: for a given amino acid, codon
usage is biased in many proteins towards a higher fre-
quency of certain codons above others. The coordination of
the concentration of a particularly modified tRNA with the
frequency of its cognate codon in the mRNAs introduces
an additional level of regulation to fine-tune translation and
influences the translation rate for each protein [8, 57].
Furthermore, the 64 possible codon variants outnumber the
amount of tRNA molecules raising the necessity of wobble
base pairing [58]. Nucleoside modifications at the wobble
position 34 of tRNA increase the capabilities of tRNA to
decode multiple synonymous mRNA codons differing by
the third nucleoside. tRNA modifications through modu-
lating the codon–anticodon affinity regulate also the biased
translation of mRNA subsets, and adjusting the frequency
of tRNA modifications allows the cell to rapidly react to
environmental changes including different kinds of stress,
utilizing the protein synthesis capacity for the actually most
needed proteins. In E. coli, stress resistance was altered
when synonymous mutations were introduced into heat
shock genes [59].
The elaboration of the interconnection between tRNA
nucleoside modification and translation fidelity followed
different but complementing experimental paths: (1)
observation of particular phenotypes including specific
diseases triggered the discovery of the underlying defects
of enzymes responsible for nucleoside modifications in
tRNAs; (2) experimental deletion of genes encoding for
nucleoside modifying enzymes induced particular cellular
dysregulations; (3) hypersensitivity to various stress con-
ditions were connected to hypomodified tRNAs. In the
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following section, we would like to highlight some recent
findings connecting tRNA modification with translation
features.
Codon–anticodon interactions are affected by tRNA
modified nucleosides to regulate cytoplasmic protein
translation
Already in 2007, modifications of tRNA wobble nucleo-
sides have been linked to the preferential translation of
some transcripts with particular arginine and glutamic acid
codons [60]. Trm9, a yeast methyltransferase, completes
the synthesis of 5-methylcarboxymethyl-2-thiouridine
(mcm5S2U) by adding the final methyl group. The affected
uridines were found in the wobble position of tRNAArg
(UCU) and tRNAGlu (UUC), and Trm9 activity enhanced
the synthesis of DNA damage response proteins [60]. Since
then, evidence continuously accumulated that the content
of overall tRNA nucleoside modifications was associated
with translation efficiency for particular proteins [61].
During the recent years, it was shown that lack of URM1-
and ELP-dependent tRNA wobble modifications decreased
the translation of mRNAs enriched in Lys-AAA, Gln-CAA
and Glu-GAA codons. Both, thiolation and methoxycar-
bonylmethylation of uridines in position 34 enhanced the
binding of tRNAs to the ribosome and in this way pro-
moted translation of mRNAs rich in the favored codons
[62]. Modifications in tRNA anticodon loops are necessary
to prevent frame-shift mutations. In eukaryotes, the wobble
uridine modifications mcm5 and S2 side groups at wobble
uridines are important for reading frame maintenance [63].
The phenotypes arising when U34 lacks sulfur at position 2
or the side chain at position 5 can be suppressed by over-
expression of hypomodified tRNAs. Metabolic deficiencies
in fission yeast were caused by changes in mRNA decoding
due to the lack of isopentenyl-A (i6A) modification in
position 37 [64].
A recent example of a newly discovered tRNA modifi-
cation frequently found at position 37 is a cyclic form of
N6-threonylcarbamoyladenosine (ct6A) [65]. The modifi-
cation is required for correct decoding of ANN codons. N6-
threonylcarbamoyladenosine (t6A), a modification well-
known since several decades, might have been an artifact
resulting from hydrolysis of the native ct6A in the condi-
tions used for nucleoside isolation. In physiological
conditions, ct6A shows remarkable stability [66].
Importance of wobble uridines/2-thiouridines
in codon–anticodon interaction
About 40 different modified uridines and 2-thiouridines are
found in the first (wobble) position of the anticodon.
According to the original Crick’s hypothesis uridine can
form a base pair with either adenosine or guanosine
(Fig. 3) [67]. Replacement of oxygen-2 of the uracil ring
with a sulfur atom is observed for at least ten wobble
uridines in tRNAs specific for lysine, glutamic acid and
glutamine. Many uridines at the wobble position are sub-
stituted with a side chain at the carbon C5. Both, the
presence of sulfur and the modifications at C5 control the
decoding behavior [11]. 2-Thiouridines, besides their sig-
nificant contribution to translational regulation through
codon–anticodon interactions, serve as recognition ele-
ments for cognate aminoacyl-tRNA synthetases (aa-RS)
[19, 68] and are used together with other modifications by
the innate immune system to distinguish between self and
pathogen RNAs [69–71]. Furthermore, the thiocarbonyl
function of S2U-containing human tRNALys3 is involved
in the formation of the initial complex with HIV-1 RNA as
a prerequisite for viral RNA reverse transcription [72].
Notably, 5-methyl-2-thiouridine (or 2-thioribothymidine)
is also located in the TWC loop of tRNAs of hyperther-
mophilic species such as Thermus thermophilus [73, 74]
and Pyrococcus furiosus [75]. This nucleoside is thought to
enhance the stability of the tertiary structure of tRNA at
elevated temperatures.
The thiolation status of wobble uridines directly depends
on the intracellular methionine and cysteine availability
[76]. Furthermore, a kind of intra-molecular cross-regula-
tion was discovered in yeast. A temperature-sensitive
mutant showed reduced levels of 2-thiolated U34 in
tRNAGln (UUG) as a consequence of the lacking pseu-
douridine (W) 38 modification [77]. The 2-thiouridine
(S2U) units facilitate Watson–Crick base pairing with
adenosine and the wobble pairing with G in the third
position of the codon and restrict reading of near-cognate
Fig. 3 The Watson–Crick and wobble base pairs of uridine and
2-thiouridine with adenosine and guanosine
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codons [58, 78]. Affinity measurements showed that the
S2U modification of tRNAGln significantly strengthens the
binding to glutamine codons compared to unmodified uri-
dine to enhance aminoacylation kinetics and to prevent
frame-shift errors [63, 79]. We reported previously that
S2U nucleosides can be dethiolated in the presence of
hydrogen peroxide resulting in a mixture of uridine and the
4-pyrimidinone riboside (H2U) [79]. Further analysis
revealed that the product ratio depends on the pH of the
reaction mixture [80] and on the substituent at position 5 of
the nucleobase [81]. When S2U is transformed into H2U,
the preferred base pairing with adenosine is lost in favor of
base pairing with guanosine [82]. Recently we have proved
that desulfuration process in S2U-RNA in the presence of
hydrogen peroxide is catalyzed by cytochrome c (unpub-
lished results). Moreover, experiments carried out on yeast
cultures treated with hydrogen peroxide have shown that
about 7 % of mcm5S2U-tRNA is desulfurated, mainly into
the prevailing mcm5H2U-tRNA product and only into a
minor amount of mcm5U-tRNA (unpublished).
Methyltransferases
Many tRNA base modifications consist of single methy-
lations, or—in case of more complicated structures—
include a methylation step. Therefore, tRNA methyltrans-
ferases are a class of intensively investigated enzymes.
Methylation of guanosine in tRNA position 37 carried out
by TrmD was found in many species and acts as frameshift
suppressor [83]. In higher eukaryotes, DnmT2 and NSun2
transfer methyl groups to the cytosine 5 position [39].
Knock-out of both enzymes resulted in a complete loss of
m5C, reduced protein synthesis rates and was lethal for
mice [84] and yeast cells [85]. Cytosine methylation in
tRNAAsp position 38 is important for correct amino acid
incorporation to properly discriminate between Asp and
Glu codons [84]. Other methyl transferases are Abp140 in
yeast and NSun6 in humans, producing 3-methylcytidine
(m3C) found in tRNA position 32 and m5C in position 72,
respectively [86, 87]. Methylations constitute also a major
class of modifications of mitochondrial tRNAs.
Mitochondrial tRNA modifications
Mitochondria are semi-autonomous organelles that possess
their own genomes as well as transcription and translation
machinery to provide the chemical energy required by
living cells. The human mitochondrial DNA (mtDNA)
encodes 13 proteins of the oxidative phosphorylation sys-
tem (OXPHOS), two rRNAs, and all of the 22 tRNAs (mt-
tRNA) required for mitochondrial protein synthesis. This
small (16.5 kb) mt-DNA has multiple copies in mito-
chondria; however, it is not able to express all the
components needed to sustain a functional translation
machinery. The remaining RNAs and proteins are encoded
in the nucleus, expressed in the cytosol and then imported
into mitochondria, including proteins required for synthesis
and regulation of mt-DNA, mitochondrial ribosomal pro-
teins, aminoacyl-tRNA synthetases and tRNA-modifying
enzymes [88–92].
To became functional elements of mitochondrial protein
biosynthesis, mt-tRNAs undergo numerous post-transcrip-
tional modifications [93–96]. Modifications act directly on
the structure, stability and consequently the functionality of
mt-tRNA [52, 97–99]. Modified nucleosides play key roles
in the folding process of mt-tRNAs to provide the func-
tional tertiary L-shaped structure [97]. The modifications
involved in this process are commonly base-methylated
purines, e.g., m1A, m1G, and m2,2G. The methyl group
attached to bases prevents formation of false Watson–Crick
pairings and wrong folding of mt-tRNAs. Usually, several
post-transcriptional modification steps are needed to ensure
the correct mt-tRNA folding. Surprisingly, the presence of
1-methyladenosine (m1A) at position 9 is a necessary and
sufficient requirement for the correct folding of human mt-
tRNALys to the canonical tertiary structure by prohibiting
the pairing between A9 and U64 [97, 100, 101].
tRNA modifications are essential for the decoding
capacity, recognition by aminoacyl-tRNA synthetases,
translation factors and mt-tRNA modifying enzymes [92,
93, 95, 102–104]. In mammals, 16 different modifications
were identified in 23 positions of all 22 mt-tRNAs (Fig. 4);
however, the greatest diversity of modifications was found
in nucleosides located at position 34 and 37. The mam-
malian mitochondrial decoding system differs from the
universal genetic code. Mitochondria use four non-uni-
versal codons: AUA for Met instead of Ile, UGA for Trp
instead of STOP and AGR (R = A or G) for Stop instead
of Arg [93, 94]. The reduced number of mt-tRNAs in
comparison with the cytosolic system of translation
requires a more flexible codon reading. Thus, post-tran-
scriptional modifications located at the wobble position of
mt-tRNAs play a critical role in efficiency and accuracy of
this minimal decoding system [105]. Recently, Suzuki et al.
demonstrated a first landscape of modifications in all 22
species of mt-tRNAs isolated from bovine liver [95].
Codon–anticodon pairing analysis revealed that eight mt-
tRNAs bearing Leu, Val, Ser, Pro, Thr, Ala, Arg and Gly
were found to read family box codons. In all these cases,
the conformational flexibility of unmodified U located at
position 34 enables reading of all four bases at the third
codon position. The remaining mt-tRNAs are responsible
for recognition of two codons each, including the purine-
ending codons NNA and NNG. Their post-transcriptional
wobble modifications refer to mitochondria-specific
5-substituted pyrimidines: 5-taurinomethyluridine (sm5U),
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5-taurinomethyl-2-thiouridine (sm5S2U) and 5-formylcy-
tidine (f5C) identified in mt-tRNA(Leu, Trp), mt-
tRNA(Lys, Gln, Glu) and tRNAMet, respectively [104, 105,
106]. It has been proposed that uridine derivatives of the
m5(S2) type restrict the conformational flexibility of the
wobble uridine preventing misrecognition of the near-
Fig. 4 Mitochondrial tRNA nucleoside modifications. a Distribution
of post-transcriptional modifications in mt-tRNA [90, 95]; modifica-
tions identified in mammalian mt-tRNAs are indicated in red [94];
b chemical structures of mitochondria-specific modifications located
at the anticodon wobble position: 5-formylcytidine (f5C),
5-taurinomethyluridine (sm5U), and 5-taurinomethyl-2-thiouridine
(sm5s2U); and in position 37: N6-isopentenyladenosine (i6A),
2-methylthio-N6-isopentenyladenosine (ms2i6A), N6-threonylcar-
bamoyladenosine (t6A), and 1-methylguanosine (m1G)
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cognate codons ending in cytidine or uridine [93]. Defects
in the taurine modified uridines of human tRNALeu(-
sm5UAA) and mt-tRNALys(sm5S2UUU) are associated
with two major classes of mitochondrial diseases, MELAS
and MERRF caused by point mutations in mt-RNA genes
(Fig. 2) [52, 93, 107, 108–112]. The pathogenic mutations
located in the D or T loop of tRNALeu and mt-tRNALys,
respectively [93, 105, 113–115] are supposed to disrupt the
tertiary structure of mt-tRNAs that prevents their recogni-
tion by enzymes responsible for sm5(S2)U biosynthesis
[116, 117]. The taurine-containing modifications are
believed to play an important role in stabilizing codon–
anticodon interactions in the pairing with A/G as the third
codon letter [118]. The absence of sm5U results in a defect
of translating UUG-rich genes. Among them is ND6
(NADH-ubiquinone oxidoreductase chain 6) located in
Complex I of the respiratory chain. The sm5S2U defi-
ciency results in the complete loss of pairing with both
cognate codons AAA and AAG, and reduction in Complex
I and IV activities. According to previous data [85, 119–
121], the presence of a 2-thiocarbonyl group and a tauri-
nomethyl residue in the structure of wobble sm5S2U seems
to be crucial for optimal mammalian mitochondrial
translation.
Very similar codon–specific translational defects were
also observed in the absence of 5-carboxymethy-
laminomethyl-2-thiouridine (cmnm5S2U) located at the
wobble position of S. cerevisiae mt-tRNA bearing Lys, Glu
and Gln [122]. The lack of the cmnm5U34 and 2-thiocar-
bonyl modifications caused the complete degradation of
mitochondrial tRNA, mRNA, and rRNA, instability of
mitochondrial genome, perturbation in mitochondrial
translation and consequently, respiratory defects.
Recent reports suggest that incorrect maturation of mt-
tRNA(Lys, Glu, Gln) resulting in the loss of taurine modified
uridine and 2-thiouridine can be also caused by mutations
in the genes for the mitochondrial translation optimization
factor 1 (MTO1) and tRNA 5-methylaminomethyl-2-
thiouridylate methyltransferase (TRMU) responsible for
5-methylaminomethylation and the thiolation of U34,
respectively [90, 93]. Deficiency of the MTO1 enzyme was
reported in patients with infantile hypertrophic cardiomy-
opathy whereas the mutated TRMU caused reversible
hepatopathy [90, 123, 124]. The MTO1 mediated mt-tRNA
modification has been recently presented as a novel factor
in tissue-specific regulation of OXPHOS, fine-tuning of
mitochondrial translation accuracy and balancing of mito-
chondrial and cellular secondary stress responses [125–
127].
The ability of base modifications to regulate the codon–
anticodon interactions and mt-tRNA biochemical functions
was clearly exemplified by 5-formylcytidine (f5C) [107].
The modified cytidine located at the wobble position in
mammalian mt-tRNAMet(f5CAU) is able to recognize the
non-universal AUA and the canonical AUG codons. Both
purine ending codons are decoded by a single tRNAMet that
is functional in the mitochondrial protein initiation and
elongation steps [128, 129]. In the cytosol, a single AUG
encoding methionine is recognized by two different tRNAs
attending the initiation or elongation step. Thus, the pres-
ence of wobble f5C was suggested to expand the codon
recognition capabilities of tRNAMet through enhanced
binding to the AUA codon [129, 130].
Contrary to wobble 5-substituted pyrimidines decoding
the purine-ending codons, four mammalian mt-
tRNA(Tyr, His, Asn, Asp) modified with queuosine (Q) are
responsible for recognition of pyrimidine-ending codons
(NAU/NAC). Q34 is known to restrict the conformational
flexibility of the anticodon loop by stabilization of the
U-turn [131] and has been implicated in regulating the
decoding capabilities of tRNA [132–134].
The frequency of modified nucleosides at position 37
(adjacent to the anticodon) is almost two times higher than
at the wobble position [96]. Among all known purines
identified at this position the most common are N6-
isopentenyladenosine (i6A), N6-isopenetyl-2-thiomethy-
ladenosine (mS2i6A), N6-threonylcarbamoyladenosine
(t6A) and 1-methylguanosine (m1G). On the basis of the
functional role of cytoplasmic tRNA modifications [52,
135–139], mitochondrial modified A37 are supposed to
affect the behavior of tRNAs during translation via base-
stacking stabilization of codon–anticodon interactions,
prevention of translational frame-shifting and maintaining
decoding accuracy. In fact, the 6-isopentenyl group of
i6A37 was found to improve the efficiency and accuracy of
mitochondrial translation [64]. The loss of i6A37 in human
mitochondrial tRNAs has been recently described as a
result of pathogenic mutations in the tRNA isopentenyl
transferase (TRIT1), responsible for i6A37 biosynthesis.
Defective i6A37 was reported in patients with
encephalopathy and myoclonic epilepsy [140]. In some
mammalian mt-tRNA sequences i6A37 is modified by a
mitochondrially localized methylthiotransferase,
CDK5RAP1, to form mS2i6A37 [141]. In cdk5rap1
knockout mice deficient in the 2-methylthio modification in
mt-tRNAs bearing Ser(UCN), Phe, Tyr and Trp, impaired
mitochondrial protein synthesis was observed causing
respiratory defects of mitochondria and myopathy in vivo
[142]. Furthermore, Wei et al. demonstrated that the
2-methylthio group in mS2i6A37 is sensitive to oxidative
stress and was reduced in patients with mitochondrial
disease [142].
The most abundant modification in mt-tRNA sequences
is pseudouridine (W), found at 27 positions of mt-tRNAs
(Fig. 4) [96]. Due to its unique ability to coordinate a
structural water molecule via the free N1-H, pseudouridine
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exhibits improved base stacking and thus, stabilizes higher
order RNA structures by rigidifying the nearby sugar-
phosphate backbone [143, 144]. Therefore, it is not sur-
prising that W is frequently found in characteristic
structural motifs in tRNA and rRNA, such as the junctions
of single-stranded and helical regions [145]. W is the pro-
duct of the non-reversible isomerization of uridine in the
process called pseudouridylation. The U ? W conversion
takes place within the RNA chain and is catalyzed by a
family of pseudouridine synthases (PUS) as the ‘‘writers’’
of W which employ both sequence and structural infor-
mation to achieve site specificity [146]. Mutations in the
PUS1 gene preventing the W biosynthesis in human
mitochondria cause myopathy, lactic acidosis and sider-
oblastic anemia (MLASA) [147, 148].
tRNA modification dynamics
Some tRNA nucleoside modifications show dynamic
changes (Table 1) caused by environmental factors such as
stress or nutrition. During the stress response, a widespread
reprogramming of tRNA modifications occurs [149]. The
tRNA base modifications change in a characteristic manner
depending on the kind of stress creating reproducible
modification patterns which can even be used to distinguish
among chemically similar stressors and to predict toxicant
chemistry [150]. In a seminal publication, Chan et al.
showed the dynamic changes of tRNA modifications dur-
ing various cellular stress conditions in yeast [151]. They
demonstrated that tRNA modifications such as Cm, m5C
and m2,2G (N2,N2-dimethylguanosine) enabled cells to
better survive in the presence of H2O2 and that the
oxidative stress controls the degree of tRNA modifications.
An increase in cytosine methylation upon oxidative stress
was also shown for the yeast tRNALeu (CAA) which con-
tains m5C at the wobble position, methylated by the Trm4
methyltransferase. The increased proportion of m5C con-
taining tRNAs upon exposure to hydrogen peroxide
resulted in increased translation of mRNAs enriched in the
corresponding UUG codons [152]. Also in yeast tRNAHis,
the level of m5C was raised in different stress conditions
and was accompanied by growth arrest [153]. In mam-
malian systems, oxidative stress caused an increase in the
5-methylcarboxymethyl-20-O-methyluridine (mcm5Um)
modification to promote the expression of selenocysteine
containing proteins which contribute to detoxification of
reactive oxygen species [154].
Lack of specific modifications can cause stress-sensitive
phenotypes. The histone acetyltransferase Sin3/Elp3, a
component of the Elongator complex, is required for the
modification of the wobble nucleoside in tRNALys (UUU).
In fission yeast cells lacking Sin3/Elp3, the wobble U
nucleoside in tRNALys, tRNAGlu and tRNAGln is not
modified which causes a phenotype highly sensitive to
oxidative stress [155]. The anticodon loop modifications
carried out by Sin3/Elp3 optimize translation efficiency for
survival of oxidative stress. The dynamics can be further
amplified by negatively affecting the translation of tran-
scription factors such as Atf1 and Pcr1 which are required
for the transcription of stress response genes [155]. The
mRNAs for Atf1 and Pcr1 contain an elevated AAA:AAG
ratio for Lys codons, thus they are more efficiently trans-
lated during stress than, e.g., house-keeping genes which in
general show low AAA:AAG ratios [56]. In special situa-
tions, the lack of modifications can also be of advantage. It
was demonstrated that defects in tRNA uridine thiolation
confers resistance to ER stress due to a generally decreased
translation rate [156].
Influence of sulfur at C2 and C5-substitutions
on the base pairing of wobble uridines/2-
thiouridines
RNA duplexes containing a S2U-A base pair are thermo-
dynamically more stable than those with a U-A base pair
due to a preferential S2U C30-endo sugar ring pucker,
improved base stacking in RNA chains [157] and an
enhanced overall A-type RNA duplex helical structure
[158–166]. Early data [159] suggested that Nature had
introduced 2-thiouridine into the wobble position to pre-
serve hybridization to adenosine, and to restrict the wobble
pairing with guanosine [167]: the wobble S2U-G base pair
is less stable than U-G and the presence of sulfur favors
S2U-A over S2U-G base pairs (Fig. 3).
However, the presence of C5 side chains can change the
preference for U-A base pairing and biological studies
suggested favored reading of the 30-G-ending codons by
anticodons when the 2-thiouridines contained 5-substitu-
tions [168]. The substituent at the position C5, through its
electron withdrawing/donating properties, contributes to
the electron density within the p system of a nucleobase.
This feature strongly depends on the geometry of the
5-substituent, especially if the substituent may interact with
the nucleobase electron system not only through a meso-
meric but also through an inductive effect [169].
Consequently, the loss of C5 modifications results in
distinct phenotypes in yeast and bacterial cells. Deficiency
of Trm9, a yeast methyltransferase, required for the syn-
thesis of mcm5U and mcm5S2U, resulted in decreased
translation fidelity and activation of stress response path-
ways caused by protein errors [170]. Yeast cells lacking
both, the S2- and the mcm5-uridine modification at the
wobble position showed reduced protein levels and growth
impairment mainly due to tRNALys hypomodification
[171]. tRNA modifications also show regular changes in
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Table 1 Dynamic changes in tRNA base modifications are coordinated with cellular physiology








Cm Increased general levels in tRNAs after
exposure of yeast cells to H2O2









Increased levels at the wobble position of
tRNALeu (CAA) and tRNAHis after
exposure of yeast cells to H2O2
Increased translation of mRNAs enriched in
the corresponding UUG codons











Increased general levels in tRNAs after
exposure of yeast cells to H2O2











mcm5Um Increased levels in mammalian systems
under oxidative stress
Promotion of the expression of
selenocysteine containing proteins which














S2U H2U In the presence of H2O2, dethiolation
occurred in vitro and in yeast cells
Change in decoding preferences?




















mcm5U and mcm5S2U Oscillating levels during the cell cycle
were observed
Decreased translation fidelity and activation
of stress response pathways
Cell division regulation
Telomeric gene silencing and DNA damage
response
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normal cellular processes, as their levels oscillate together
with the cell cycle [172]. The Trm9-mediated methylation
of mcm5S2U was higher during the S phase than in G1 and
G2. The increase in the mcm5U modification during the S
phase promoted cell cycle progression by upregulating the
translation of the ribonucleotide reductase (RNR) complex
which catalyses the conversion of ribo- into deoxyribonu-
cleotides [172]. Consistent with these findings, Elongator
was shown to be involved in cell division regulation [173].
Elongator is a protein complex consisting of six subunits
conserved in eukaryotes, it has tRNA modification activity
and seems to act upstream of Trm9 [174]. Elongator par-
ticipates in the synthesis of mcm5 and 5-carbamoylmethyl
(ncm5) modifications of uridines. In addition to its role in
the cell cycle, the tRNA modification activity of the
Elongator complex controlled the expression of proteins
involved in telomeric gene silencing and DNA damage
response [175].
In gram-negative bacteria, 5-carboxymethoxyuridine
(cmo5U) and its methyl ester derivative 5-methylcar-
boxymethoxyuridine (mcmo5U) were found at the wobble
position in several tRNAs [176]. Their level in tRNAPro3
changed in a growth phase dependent manner. Both,
cmo5U and mcmo5U were suggested to facilitate wobble
base pairing with guanosine.
Oxidative stress can result in loss of the sulfur atom of
2-thiouridine. In our studies on the oxidative desulfuration
we obtained the 4-pyrimidinone products at the nucleoside
(H2U, Fig. 5b, X = H) and RNA oligonucleotide (H2U-
RNA) level [79]. Measurement of the binding affinity of
H2U to A and G complements [79, 82] indicated that the
H2U-G base pair is as stable as a U-G wobble base pair.
This is only possible if it forms a base pair in the RNA
duplex with two hydrogen bonds, which makes a move-
ment of pyrimidine residue towards the minor groove
necessary, as predicted by Takai [177]. These assumptions
were confirmed very recently by the team of Yusupova
[178], by crystallization of Escherichia coli tRNAUUU
Lys
complexed with the 70S ribosome and with a short mRNA
fragment. In this mnm5S2U-G base pair the thiouridine is
prestructured into a zwitter ionic form as shown in Fig. 5b
(with X = S- and R = mnmH?/–CH2N
?H2CH3). We also
realized that the H2U model has the identical donor/ac-
ceptor pattern as S-geranyl-2-thiouridine [179] (Fig. 5b,
X-geS). The geS2U nucleoside is a product of geranylation
of a small fraction (ca. 7 %) of the wobble mnm5S2U and
cmnm5S2U present in tRNALys, tRNAGlu and tRNAGln.
The binding mode of geS2U with G is the same as in H2U-
G, as suggested by us and others [11, 180].
Base modifications of mRNA
Nucleoside modifications identified in mRNA include N6-
methyladenosine (m6A), N1-methyladenosine (m1A),
5-methylcytidine (m5C), 5-hydroxymethylcytosine
(hm5C), and pseudouridine (W) (Fig. 6) [5, 181–188].
Naturally, m6A is the most abundant modification found in
mRNAs and also in non-coding RNAs [189, 190]. The
m6A modifications in mRNA are preferentially found in
coding sequences around the stop codon and in 30-un-
translated regions [191]. Through its influence on mRNA
processing, m6A was shown to influence circadian rhythms
[192]. In mammalian cells, METTL3 and METTL4 were
identified as the methyltransferases modifying adenosine,
and the methyl group can be removed from m6A, e.g. by
FTO or ALKBH5 demethylases [193–195]. The identifi-
cation of m6A demethylases suggests a dynamic regulation
of adenosine methylation [196]. As a reader of the infor-
mation encoded by the m6A modification, the YTH
domain-containing family protein 2 (YTHDF2) was iden-
tified [197, 198]. Very recently, dynamic m6A methylation
was described to control translation rates in the heat shock
response [199]. During the heat shock, YTHDF2 is relo-
cated from the cytoplasm to the nucleus and the
methylation of a few adenosines within the 50-UTR of
Table 1 continued




















cmo5U and mcmo5U Levels change in a growth phase-
dependent manner
High levels facilitate wobble base pairing
with guanosine and pyrimidines
The levels of modified nucleosides change in oxidative stress conditions, with the cell cycle progression, or during different growth phases of
bacteria
Cm 2’-O-methylcytidine, m5C 5-methylcytidine, m2,2G N2,N2-dimethylguanosine, mcm5Um 5-methylcarboxymethyl-20-O-methyluridine, S2U
2-thiouridine, H2U pyrimidinone nucleoside, cmo5U 5-carboxymethoxyuridine, mcmo5U 5-methylcarboxymethoxyuridine
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newly transcribed mRNAs is increased. Translation initi-
ation of these mRNAs becomes independent from the 50-
CAP structure [199]. The 50-CAP-independent translation
depends on ribosome binding inside the 50-UTR that can be
mediated by eIF3 binding to a single m6A [200]. Dynamic
alterations in the amount of m6A in 50UTR during stress
conditions enable CAP-independent translation and answer
a long-standing question about the mechanism of selective
protein synthesis when CAP-dependent translation is sup-
pressed. In other publications, YTHDF2 was described to
promote relocation and degradation of m6A containing
mRNAs [185, 197]. In general, the m6A modification
destabilizes RNA duplexes and reduces secondary structure
[201]. Alterations in the secondary structure by the pres-
ence of m6A can increase the accessibility of RNA for the
binding of other proteins such as heterogeneous nuclear
ribonucleoprotein C (HNRNPC), a nuclear protein
involved in pre-mRNA processing [198], or YTHDF1,
which increases translation efficiency of mRNAs contain-
ing m6A near stop codons [202]. Among the mRNAs
containing conserved m6A modifications are transcripts
encoding pluripotency factors [203]. Lack of m6A after
depletion of Mettl3 was shown to prevent the differentia-
tion of pluripotent stem cells into specific lineages and to
preserve the pluripotent stem cell status [203, 204]. The
results were confirmed by a recent study showing that the
reprogramming of mouse embryonic fibroblasts into
pluripotent stem cells was promoted by m6A [205].
As m6A was found in coding regions of mRNA it may
exert a direct influence on codon–anticodon interactions. As
demonstrated very recently, the presence of m6A within a
codon decelerates cognate-tRNA decoding [206]. The
influence of mRNA base modifications on decoding was
further analyzed in an experimental system in which
methylation of guanosine was introduced at different codon
positions in mRNAs. O6-methylguanosine (m6G) in the first
and third codon position severely impaired correct tRNA
selection, while the same modification at the second position
did not show erroneous coding but a more than 1000-fold
decrease in translation rate [207]. Quantitative mass
spectrometry of mammalian mRNA preparations identified
N1-methyladenosine (m1A) with an overall frequency of
0.015–0.16 % of all adenosines [208]. Under physiological
conditions, this modification introduces a positive charge
which is expected to strongly affect the decoding process.
m1A was preferentially found around start codons and its
presence increased translation efficiency [208].
In addition, studies carried out on human and yeast tran-
scriptomes identified hundreds of pseudouridine (W) sites in
mRNA [183, 184, 209]. The studies suggest that mRNA
pseudouridylation is an ancient, evolutionarily conserved
mechanism. In non-coding RNAs, W is one of the most
widespread post-transcriptional modifications, highly con-
served among species. The site-specific pseudouridylation of
eukaryotic mRNAs is a genetically programmed RNA
modification that naturally occurs in multiple transcripts via
distinct mechanisms providing important regulatory func-
tions [210]. Further research is required to identify the
pseudouridine ‘‘readers’’, proteins that specifically bind toW
sites on the mRNA. The development of a novel sequencing
methodology allowing to identifyW in non-coding RNA at a
single nucleotide level revealed that the number of W sites
may dynamically increase in environmental stress condi-
tions (heat shock stimuli, nutrient deprivation or serum
starvation) [183, 184, 209]. In an experimental approach,
pseudouridylation targeted to uridines at the first position in
stop codons was shown to suppress translation termination
both in vitro and in vivo [211]. The translation termination
codons were converted into coding triplets demonstrating
once more the fundamental influence of nucleoside modifi-
cations on the codon recognition.
The 5-methylcytidine (m5C) mRNA base modification
shows low abundance in coding regions and is found
mainly in untranslated regions [212]. A function in
miRNA targeting was suggested for m5C as its occur-
rence in the 30-UTR correlates with Argonaute binding
sites. m5C can be oxidized by Tet enzymes to the
hydroxymethylcytosine nucleoside which has a positive
effect on mRNA translation [188]. Investigations in
Drosophila revealed that the brain was especially rich in
Fig. 5 Base pairing between
modified uridines and
guanosine. a The conventional
wobble base pair between
mnm5U or mnm5S2U and
guanosine; b base pairing of a
H2U-type nucleoside with
guanosine (X = H for H2U,
X = S- for a model proposed
for a novel base pair between
zwitter ionic mnm5S2U and
guanosine, X = geS for
mnm5geS2U)
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hmC, and the flies did not survive a complete loss of RNA
hydroxymethylation [188].
Nucleoside modifications in other non-coding RNA
(ncRNA)
Base modifications of non-coding RNA was a rather
unexplored research field until recently. Analyses using
an anti-m6A-antibody followed by RNA-sequencing
(RNA-seq) revealed that also a significant fraction of
miRNAs contains m6A [213]. The m6A modifications
mark pri-miRNAs, the precursors of pre-miRNAs, for
proper processing by the DROSHA ribonuclease and
DGCR8 [214]. In addition, the abundance of miRNAs was
controlled by m6A as knock-down of the m6A demethy-
lase FTO affected the levels of some miRNAs [213].
Conversely, the formation of m6A in mRNA was shown
to be regulated by miRNAs through a sequence pairing
mechanism. Over-expression of certain miRNAs signifi-
cantly increased the m6A abundance at the miRNA
binding sites by a mechanism including the interaction of
the miRNA processing enzyme Dicer with METTL3
[215]. In nuclear transcripts, m6A is part of a consensus
motif which is recognized by the HNRNPA2B1 RNA
binding protein to regulate alternative splicing [213]. The
regulation of the miRNA pathway and the alternative
splicing events by modified nucleotides adds new layers
of complexity to the posttranscriptional regulation of gene
expression.
Fig. 6 mRNA modifications and their functions. 50- and 30-untranslated regions (UTR), as well as start (AUG) and stop (UGA) codons are
indicated. The colors of the marks along the mRNA correspond to the specific modified nucleosides
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Delayed translation adversely affects cell functions
During the last 2 years, the consequences of restrained
peptide bond formation caused by low abundance of
specific tRNAs or aberrations in tRNA modifications were
clarified. In 2014, O’Brian and colleagues found a corre-
lation between translation speed and the correct folding of
the nascent peptide chains [216, 217]. The translation
speed, the rate with which amino acids are added to the
growing peptide chain, depends on the codon usage in the
mRNA, codons binding abundant tRNAs are processed
faster [218, 219]. Strikingly, a more rapid translation
facilitated the right peptide folding so that the frequency of
a particular codon and the concentration of its cognate
tRNA exerted an influence on the quality of the protein
production.
In 2015, Nedialkova and Leidel confirmed and expanded
these findings by showing that ribosome pausing at codons
with low abundancy of their cognate tRNAs increased
protein misfolding and aggregation which eventually
resulted in impaired protein homeostasis and cellular dys-
function [220]. The ribosome pausing had been
demonstrated earlier by determination of the in vivo ribo-
some distribution on the mRNA at single codon resolution
[221]. Deng et al. demonstrated that enhanced ribosome
pausing in yeast facilitates down-regulation of the expres-
sed proteins [222]. It was also suggested that the existence
of a ‘codon ramp’, a stretch of 30–50 codons enriched with
suboptimal codons, slows down translation to avoid
downstream crowding of ribosomes [223]. However, the
influence of translation speed seems to affect more func-
tional features of proteins including the microdomain
structures of intrinsically disordered regions [224, 225]. An
unusual example for non-optimal codon usage required for
a functioning circadian rhythm has been described in
Neurospora. Codon optimization for the clock protein FRQ
not only increased the protein level and disturbed the cir-
cadian rhythms, but also resulted in conformational
changes in the FRQ protein [26]. The speed of ribosome
movement can even exert a kind of feedback control on the
translation initiation efficiency [226]. Consequently, tRNA
modifications and their dynamic changes influence the
translation elongation rate to control not only protein levels
but also the quality of protein folding.
Conclusion
To prevent the simultaneous execution incompatible cel-
lular programs the schedule of gene expression has to be
harmonized within a reasonable response time. This control
includes the adjustment of the concentration and stability
of mRNAs as executed by transcription regulation, splic-
ing, nuclear export, RNA interference, etc. to subsequently
favor the synthesis of required proteins while decreasing
the production of actually not needed ones. Furthermore,
mechanisms are required during life-threatening events to
immediately shut down overall protein production and to
concentrate the cells’ capacity on the synthesis of rescue
proteins able to ease the stressful conditions. The tRNA
molecules have evolved as stress sensors and mediators of
immediate early stress response pathways due to their
central role in protein translation. tRNAs and tRNA-
derived fragments contribute to the control of apoptosis,
stress signaling, and RNA interference. The presence or
absence of tRNA nucleoside modifications modulate these
processes by (1) controlling enzymatic tRNA cleavage
determining the concentration of tRNA halves with stress
signaling function, and (2) influencing translation fidelity
to promote or ignore specific codons resulting in biased
translation of mRNAs. The redundancy of the genetic code
allows for such preference shifts in codon usage and that is
why position 34 in tRNAs, the wobble nucleoside, is a
common target for translation-altering modifications. A
bewildering number of tRNA base variations have been
described and with high probability more are waiting to be
discovered.
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